Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024
31 janv. 2024 08h45 HE
|
Autonomix Medical, Inc.
THE WOODLANDS, TX., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...
Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio
30 janv. 2024 12h00 HE
|
Autonomix Medical, Inc.
Autonomix now wholly owns development and commercialization rights to its technology in all indications Re-acquisition broadens Autonomix’s development and strategic opportunities THE WOODLANDS,...
Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use
30 janv. 2024 09h05 HE
|
Autonomix Medical, Inc.
Autonomix now wholly owns development and commercialization rights to its technology in all indications Re-acquisition broadens Autonomix’s development and strategic opportunities THE WOODLANDS,...
Autonomix Medical, Inc. Successfully Completes Preclinical Safety Study to Support Program Advancement into First-in-Human Clinical Study to Treat Pancreatic Cancer Pain Through Transvascular Ablation
12 janv. 2024 10h00 HE
|
Autonomix Medical, Inc.
Patented two-fold technology in development to locate, ablate and confirm successful ablation of specific nerves for pain management and other uses All safety inputs met with no reported...
Autonomix Medical, Inc. Completes Formation of Engineering Development Team and Provides Project Update
11 janv. 2024 10h00 HE
|
Autonomix Medical, Inc.
Appointment of Marco Bedoya, a proven leader in medical device mechanical engineering, as Director of Product Development Engagements secured with preeminent firms to drive design and development...
Autonomix Medical, Inc. to Present at the Startup Investing Webinar
11 janv. 2024 09h00 HE
|
Autonomix Medical, Inc.
Live webcast roundtable discussion featuring Autonomix, Knightscope, and Infinity Fuel on Thursday, January 11th at 2:00 PM ET THE WOODLANDS, TX, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Autonomix...
Autonomix Medical, Inc. Provides Business Overview and Highlights Upcoming Milestones
04 janv. 2024 10h00 HE
|
Autonomix Medical, Inc.
Company developing potential breakthrough technology for the nervous system Patented two-fold technology that can potentially detect problematic neural signals and ablate nerves in one simple...
Autonomix Medical, Inc. to Participate in the Virtual Investor Fireside Chat
14 déc. 2023 10h15 HE
|
Autonomix Medical, Inc.
Live moderated video webcast on Tuesday, December 19th at 3:00 PM ET THE WOODLANDS, TX, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...
Autonomix Medical, Inc. to Present at the Virtual Investor Event Titled “A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System”
06 déc. 2023 14h00 HE
|
Autonomix Medical, Inc.
Live moderated video webcast on Monday, December 11 at 2:00 PM ET THE WOODLANDS, TX, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...